Subscribe
Data & Research
4 min read

Clean-label kibble is swapping synthetic antioxidants for botanicals, grape seed included

Pet food is swapping synthetic antioxidants for botanicals like grape seed, a clean-label shift with a toxicity-perception catch.

Written by
The Underbite
Published on
June 30, 2026
Clean-label kibble is swapping synthetic antioxidants for botanicals, grape seed included

Set aside the market-sizing forecast. A $90 million niche a decade out is a rounding error in a pet food industry measured in the tens of billions. The signal worth reading in a new grape seed extract report is the substitution it tracks: premium kibble makers trading synthetic antioxidants for plant-based ones. And in this case, doing it with an ingredient many owners associate with poisoning their dog.

What the FMI report actually says

The forecast is the least interesting part. Future Market Insights values grape seed extract in pet food at $48.3 million in 2025, growing to a projected $90.4 million by 2036 at a 4.3% compound rate. Treat the precision as directional at best, because vendor market-sizing on a niche ingredient is an estimate stacked on assumptions.

The useful detail sits underneath. Dry extract is pegged at 64.7% of the category and dry food at 57% of demand, because the job is oxidation control in premium kibble. The report frames the driver as clean-label pressure, with manufacturers swapping synthetic antioxidants for standardized botanicals.

Two other threads matter more than the headline number. The report cites research from Sandri and colleagues in December 2024 finding that dietary grape proanthocyanidins improved gut microbiota balance and serotonin-to-cortisol ratios in dogs, which gives formulators a functional-nutrition story beyond preservation. And it ties supply to upcycled wine-industry byproducts, a circular-sourcing angle with real marketing value.

Why the substitution trend matters more than the forecast

The grape seed number is small. The behavior it points to is not.

The real story is antioxidant substitution, not grape seed

Premium and clean-label positioning is pushing synthetic antioxidants like BHA, BHT, and ethoxyquin off ingredient panels, and something has to keep the fats in kibble from going rancid. Botanicals fill the gap, whether that is rosemary extract, mixed tocopherols, green tea, or grape seed. Grape seed is one entrant in a category-wide shift toward natural preservation, and that shift is the thing operators should track, not any single polyphenol.

The toxicity perception the report ignores

Grapes and raisins can cause acute kidney injury in dogs and rank among the best-known pet toxins. Standardized, deseeded grape seed extract is a different ingredient and already appears in some canine supplements, but the word grape on a dog-food panel is a consumer-education problem no forecast captures. Any brand putting it on a bag inherits a marketing and labeling burden that rosemary or tocopherols simply do not carry. The report is silent on this. Operators cannot afford to be.

Upcycling is the more durable pitch

The sturdier story is sourcing. Turning wine-industry byproducts into a functional ingredient supports a circular-economy narrative that resonates in premium pet food, and it shows up in deal flow. The report points to a July 2024 Omya and Alvinesa partnership to distribute upcycled grape-derived ingredients in North America, alongside broader premium-pet investment like General Mills buying Whitebridge Pet Brands and Nestle Purina opening a new wet-food plant in Brazil.

The supplier field, from Indena and Nexira to Kemin and Naturex under Givaudan, is competing on standardization, documentation, and traceability rather than price. That is the tell that this is an ingredient chasing premium formulations, not a commodity race.

What decides whether grape seed reaches the bag

Watch the ingredient panels of the big premium brands, not the forecast. If Blue Buffalo, Purina Pro Plan, or Hill's start listing grape seed extract rather than defaulting to rosemary and tocopherols, the substitution is real. If they do not, grape seed stays a specialty-brand talking point.

Two forces will shape it. Regulatory and safety documentation, since novel botanicals need extensive substantiation before a large manufacturer will touch them. And the consumer narrative, because a category built on clean-label trust cannot afford a headline that conflates grape seed extract with grape toxicity.

The through-line for operators is simple. Natural preservation is winning in premium pet food. Which botanical wins is still open, and grape seed carries both a promising functional story and a perception problem the marketing has not yet solved.

Source: Grape seed extract in pet food report via PR Newswire

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
CompanAIn names animal health veteran Brük Herbst COO
People
4 min read

CompanAIn names animal health veteran Brük Herbst COO

CompanAIn, a Charleston company building an AI-native health platform for dogs, cats and horses, named Brük Herbst chief operating officer. Herbst, a former IDEXX, Covetrus and Zomedica executive, will lead its move from platform validation to commercial scale.

Read article
Read article
Pivotal Group buys animal health manufacturer Precision Science
Funding & M&A
3 min read

Pivotal Group buys animal health manufacturer Precision Science

Pivotal Group, a Phoenix investment firm, has acquired Precision Science, a Phoenix animal health contract manufacturer founded in 1989. Pivotal said a 130,000-square-foot North Phoenix plant, two-thirds complete, will add three manufacturing lines and expand into liquids.

Read article
Read article
Loyal taps Argenta for early development of its LOY-003 dog drug
Strategy
3 min

Loyal taps Argenta for early development of its LOY-003 dog drug

Loyal has brought in animal health contract manufacturer Argenta to support early-stage development of LOY-003, its daily pill for large and giant-breed dogs.

Read article
View all articles